bioCSL has commenced distribution of Immucor’s Capture technology platform and reagents in Australia and New Zealand. Capture is antibody detection technology used in the crossmatching of blood used for transfusion.
The technology is said to work differently from the techniques commonly used in Australia, delivering high levels of specificity and potentially reducing both the need for additional testing and delays for patients awaiting a blood transfusion. The product has a high degree of sensitivity for detection of clinically significant antibodies, providing confidence and accuracy in pre‐transfusion and prenatal screening.
Phone: 1300 369 559
AdipoGen Life Sciences DYRK inhibitors
Leucettinibs provide research tools and potential leads for further optimisation towards...
GroPep Bioreagents IGF-1 Family Proteins
IGF-1 proteins are available in different sizes, and all GroPep Bioreagents are freeze-dried and...
LSBio PathPlus Neuroscience Antibodies
LSBio PathPlus Neuroscience Antibodies are suitable for immunohistochemistry (IHC) applications...
